-
EP2349334
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2349334
| EP2349334 - S1P RECEPTOR AGONISTS FOR THE TREATEMENT OF CEREBRAL MALARIA [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 27.09.2013 Database last updated on 28.06.2024 | Most recent event Tooltip | 27.09.2013 | Application deemed to be withdrawn | published on 30.10.2013 [2013/44] | Applicant(s) | For all designated states Lexicon Pharmaceuticals, Inc. 8800 Technology Forest Place The Woodlands, TX 77381 / US | [2011/31] | Inventor(s) | 01 /
BACHRACH, Max 38 Clingstone Place The Woodlands Texas 77382 / US | 02 /
FINNEY, Constance Ann Marjory 224 Beverley Street Toronto Ontario M5T 1Z3 / CA | 03 /
KAIN, Kevin Charles 27 Cortleigh Blvd. Toronto Ontario M4R 1K5 / CA | 04 /
ORAVECZ, Tamas 206 Oakwood Place The Woodlands Texas 77389 / US | [2011/31] | Representative(s) | Hewson, Timothy John, et al Abel & Imray 20 Red Lion Street London WC1R 4PQ / GB | [N/P] |
| Former [2011/31] | Hewson, Timothy John, et al Abel & Imray 20 Red Lion Street London, WC1R 4PQ / GB | Application number, filing date | 09752585.1 | 29.10.2009 | [2011/31] | WO2009US62502 | Priority number, date | US20080109991P | 31.10.2008 Original published format: US 109991 P | US20090229970P | 30.07.2009 Original published format: US 229970 P | [2011/31] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010051349 | Date: | 06.05.2010 | Language: | EN | [2010/18] | Type: | A1 Application with search report | No.: | EP2349334 | Date: | 03.08.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.05.2010 takes the place of the publication of the European patent application. | [2011/31] | Search report(s) | International search report - published on: | EP | 06.05.2010 | Classification | IPC: | A61K45/06, A61P33/06, A61K31/13 | [2011/31] | CPC: |
A61K31/13 (EP,US);
A61K39/395 (EP,US);
A61K45/06 (EP,US);
A61K9/0014 (EP,US);
A61K9/7061 (EP,US);
A61P13/00 (EP);
A61P25/08 (EP);
A61P29/00 (EP);
A61P33/06 (EP);
| C-Set: |
A61K31/13, A61K2300/00 (EP,US);
A61K39/395, A61K2300/00 (US,EP) | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2011/31] | Title | German: | S1P-REZEPTOR-AGONISTEN ZUR BEHANDLUNG VON ZEREBRALER MALARIA | [2011/31] | English: | S1P RECEPTOR AGONISTS FOR THE TREATEMENT OF CEREBRAL MALARIA | [2011/31] | French: | AGONISTES DES RÉCEPTEURS S1P DESTINÉS AU TRAITEMENT DU PALUDISME CÉRÉBRAL | [2011/31] | Entry into regional phase | 23.05.2011 | National basic fee paid | 23.05.2011 | Designation fee(s) paid | 23.05.2011 | Examination fee paid | Examination procedure | 23.05.2011 | Examination requested [2011/31] | 10.11.2011 | Amendment by applicant (claims and/or description) | 03.05.2013 | Application deemed to be withdrawn, date of legal effect [2013/44] | 10.06.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2013/44] | Fees paid | Renewal fee | 11.10.2011 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.10.2012 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2008079382 (ABBOTT LAB [US], et al) [X] 6,8,12-14 * page 28, line 31 * * page 36, lines 19,27,28 *; | [DX]WO2008018447 (KYORIN SEIYAKU KK [JP], et al) [DX] 6,8,12-14 * refer to EP0253038 *; | [X]EP2053038 (KYORIN SEIYAKU KK [JP]) [X] 6,8,12-14 * page 11, line 54 - page 12, line 6 * * paragraph [0005] *; | [X]US5604229 (FUJITA TETSURO [JP], et al) [X] 6,8,10-16 * column 177, lines 20-24; example 28 *; | [X]WO2005118523 (NOVARTIS AG [CH], et al) [X] 6,8 * page 19, paragraph 4; example 18 * * page 21, paragraph 7 - page 221 *; | [Y]WO2008124210 (UNIV EMORY [US], et al) [Y] 1-16 * page 9, lines 26-29 *; | [DY] - GOLENSER J ET AL, "Conventional and experimental treatment of cerebral malaria", INTERNATIONAL JOURNAL FOR PARASITOLOGY, (200605), vol. 36, no. 5, ISSN 0020-7519, pages 583 - 593, XP002567354 [DY] 1-16 * the whole document * DOI: http://dx.doi.org/10.1016/J.IJPARA.2006.02.009 | [Y] - YAÑEZ D M ET AL, "Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 15 AUG 1996,, (19960815), vol. 157, no. 4, pages 1620 - 1624, XP002563336 [Y] 1-16 * the whole document * | [Y] - SCHETTERS T ET AL, "Cerebral lesions in mice infected with Plasmodium berghei are the result of an immunopathological reaction", TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, ELSEVIER, GB, vol. 83, ISSN 0035-9203, (19890101), pages 103 - 104, (19890101), XP023100701 [Y] 1-16 * page 103, column 2 * DOI: http://dx.doi.org/10.1016/0035-9203(89)90615-9 |